Donald Brooks
Impact in
-
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
-
- Erythropoietin and Anemia Treatment
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- Viral Infections and Outbreaks Research 2
- Oncology 4
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 2
- Lung Cancer Research Studies 2
- Co-authors
- Paul R. Dragsten (1 shared paper)Bo E. Hedlund (1 shared paper)Raymond Taetle (1 shared paper)Deeksha Deep (1 shared paper)Nicolas Chevrier (1 shared paper)David Álvarez (1 shared paper)Motohiko Kadoki (1 shared paper)Magali Soumillon (1 shared paper)
- Journals
- Epidemiology and Infection (1 paper)British Journal of Haematology (1 paper)MMWR Morbidity and Mortality Weekly Report (1 paper)Vaccine (1 paper)Vaccines (1 paper)
- Partner nations
- United StatesSwitzerlandRepublic of the Congo
In The Last Decade
Donald Brooks
14 papers receiving 178 citations
Peers
Comparison fields: 5 of 59
- Immunology 53
- Hematology 28
- Health 20
- Oncology 50
- Genetics 18
Countries citing papers authored by Donald Brooks
This map shows the geographic impact of Donald Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Brooks more than expected).
Fields of papers citing papers by Donald Brooks
This network shows the impact of papers produced by Donald Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Brooks. The network helps show where Donald Brooks may publish in the future.
Co-authors
The 25 scholars most cited alongside Donald Brooks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 63 | |
| 2 | 1996 | 35 | |
| 3 | Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients. | 2001 | 23 |
| 4 | 2024 | 13 | |
| 5 | Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors. | 2002 | 12 |
| 6 | 1995 | 9 | |
| 7 | 1984 | 7 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 4 | |
| 10 | 1990 | 4 | |
| 11 | 2024 | 3 | |
| 12 | 1999 | 3 | |
| 13 | A phase I study of etoposide phosphate plus paclitaxel. | 1996 | 2 |
| 14 | 2025 | 1 |
About Donald Brooks
Donald Brooks is a scholar working on Infectious Diseases, Oncology, Molecular Biology, Health and Epidemiology, having authored 14 papers that have together received 184 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Vaccine Coverage and Hesitancy (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer therapeutics and mechanisms (2 papers), Lung Cancer Research Studies (2 papers), COVID-19 epidemiological studies (2 papers) and Viral Infections and Outbreaks Research (2 papers). The work is most often cited by research in Immunology (53 citations), Hematology (28 citations), Health (20 citations), Oncology (50 citations) and Genetics (18 citations). Donald Brooks has collaborated with scholars based in United States, Switzerland and Republic of the Congo. Frequent co-authors include Paul R. Dragsten, Bo E. Hedlund, Raymond Taetle, Deeksha Deep, Nicolas Chevrier, David Álvarez, Motohiko Kadoki, Magali Soumillon, Pamela J. Kling and Robin Roberts. Their work appears in journals such as Epidemiology and Infection, British Journal of Haematology, MMWR Morbidity and Mortality Weekly Report, Vaccine and Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.